SOX12 and leukemia: Moreover, treatment of cells with l-asparaginase, which degrades asparagine and is used to treat leukemia, significantly reduced SOX12-induced CRC cell proliferation and metastasis, representing a potential therapeutic treatment for patients with CRC.